Eli Lilly and Co. (LLY.N: Quote, Profile, Research) said on Wednesday it does not expect sales of its blockbuster schizophrenia drug Zyprexa to be harmed by a recent study that showed a far cheaper older drug was equally effective.
Eli Lilly and Co. (LLY.N: Quote, Profile, Research) said on Wednesday it does not expect sales of its blockbuster schizophrenia drug Zyprexa to be harmed by a recent study that showed a far cheaper older drug was equally effective.